// App-Quantinova.ai

: Severe refractory active thyroid eye disease: an unmet clinical need in Europe

Researchers

Presenter

  • Ploutarchos Tzoulis

Principal Investigators

  • Chrysoula Dosiou

Medical Centers

  • IASO General Clinic, Department of Endocrinology, Marousi, Greece

  • University College London, Department of Experimental and Translational Medicine, London, United Kingdom

  • Stanford University, School of Medicine Division of Endocrinology, Stanford

Locations

  • Greece

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Congenital disorder

  • Genetic Disorder

  • Central Nervous System (CNS)

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

  • Endocrine/metabolic Diseases (ME)

Disease

  • Congenital hyperthyroidism

  • Thyrotoxicosis

  • Hypothyroidism

  • Psoriasis

  • Cap myopathy

  • Insomnia

  • Vitiligo

  • Coronavirus disease

Biomarkers

  • Cellular apoptosis susceptibility protein

  • Interleukin 6

Drug/Treatment

  • Methylprednisolone

  • Glucocorticoid

  • Levothyroxine

  • ILS-969

  • Tocilizumab

  • Felimazole

  • Interleukin

  • Selenium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved